RX.V
Biosyent Inc
Price:  
11.98 
CAD
Volume:  
2,600.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RX.V Relative Valuation

0.2%
Upside

As of 2025-07-06, the Relative Valuation of Biosyent Inc (RX.V) is 12.00 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 11.98 CAD, the upside of Biosyent Inc based on Relative Valuation is 0.2%.

The range of the Relative Valuation is 12.00 - 12.00 CAD.

Range Selected
Trailing P/E multiples 17.6x - 17.6x 17.6x
Forward P/E multiples 15.6x - 15.6x 15.6x
Fair Price 12.00 - 12.00 12.00
Upside 0.2% - 0.2% 0.2%
11.98 CAD
Stock Price
12.00 CAD
Fair Price

RX.V Relative Valuation - Historical P/E Data

Date P/E
2025-06-18 17.07
2025-06-17 17.04
2025-06-16 17.20
2025-06-13 17.47
2025-06-12 17.60
2025-06-11 17.58
2025-06-10 17.47
2025-06-06 17.52
2025-06-05 17.16
2025-06-04 17.06
2025-06-03 17.06
2025-06-02 16.94
2025-05-30 17.30
2025-05-29 17.22
2025-05-28 17.45
2025-05-27 17.52
2025-05-26 17.52
2025-05-23 17.52
2025-05-22 17.23
2025-05-21 17.16
2025-05-20 17.16
2025-05-16 17.23
2025-05-15 15.79
2025-05-14 15.76
2025-05-13 15.84
2025-05-12 15.96
2025-05-09 15.91
2025-05-08 16.13
2025-05-07 15.98
2025-05-06 16.13
2025-05-05 16.09
2025-05-02 16.06
2025-05-01 15.84
2025-04-30 15.98
2025-04-29 16.10
2025-04-28 15.69
2025-04-25 15.40
2025-04-24 15.03
2025-04-23 15.24
2025-04-22 15.09
2025-04-21 15.05
2025-04-17 15.40
2025-04-16 15.75
2025-04-15 15.05
2025-04-14 14.67
2025-04-11 15.19
2025-04-10 14.67
2025-04-09 15.37
2025-04-08 14.74
2025-04-07 14.89